APA

Inoda S., Morita R., Hirohashi Y., Torigoe T., Asanuma H., Nakazawa E., Nakatsugawa M., Tamura Y., Kamiguchi K., Tsuruma T., Terui T., Ishitani K., Hashino S., Wang Q., Greene M. I., Hasegawa T., Hirata K., Asaka M. & Sato N. (20110211). The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. : Experimental and molecular pathology.

Chicago

Inoda Satoko, Morita Rena, Hirohashi Yoshihiko, Torigoe Toshihiko, Asanuma Hiroko, Nakazawa Emiri, Nakatsugawa Munehide, Tamura Yasuaki, Kamiguchi Kenjiro, Tsuruma Tetsuhiro, Terui Takeshi, Ishitani Kunihiko, Hashino Satoshi, Wang Qiang, Greene Mark I, Hasegawa Tadashi, Hirata Koichi, Asaka Masahiro and Sato Noriyuki. 20110211. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. : Experimental and molecular pathology.

Harvard

Inoda S., Morita R., Hirohashi Y., Torigoe T., Asanuma H., Nakazawa E., Nakatsugawa M., Tamura Y., Kamiguchi K., Tsuruma T., Terui T., Ishitani K., Hashino S., Wang Q., Greene M. I., Hasegawa T., Hirata K., Asaka M. and Sato N. (20110211). The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. : Experimental and molecular pathology.

MLA

Inoda Satoko, Morita Rena, Hirohashi Yoshihiko, Torigoe Toshihiko, Asanuma Hiroko, Nakazawa Emiri, Nakatsugawa Munehide, Tamura Yasuaki, Kamiguchi Kenjiro, Tsuruma Tetsuhiro, Terui Takeshi, Ishitani Kunihiko, Hashino Satoshi, Wang Qiang, Greene Mark I, Hasegawa Tadashi, Hirata Koichi, Asaka Masahiro and Sato Noriyuki. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. : Experimental and molecular pathology. 20110211.